الإحصائيات الأساسية
| LEI | 549300VKJF3TJ17U4U73 |
| CIK | 1610590 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Check-Cap Ltd.
SEC Filings (Chronological Order)
توفر هذه الصفحة قائمة كاملة ومرتبة ترتيبًا زمنيًا لتصريحات هيئة الأوراق المالية والبورصات، باستثناء تصريحات الملكية التي نقدمها في مكان آخر.
| September 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For September, 2025 Commission File No. |
|
| August 27, 2025 |
Exhibit 4.35 LOAN AGREEMENT This Loan Agreement (this “Agreement”) dated as of July 2, 2025, is entered into by and between Apollo Technology Capital Corporation (formerly known as Nobul AI Corp.) (the “Borrower”) and Check-Cap Ltd. (the “Lender”). WHEREAS, the Borrower and the Lender have entered into a business combination agreement dated March 25, 2024 (as amended, the “Business Combination Agr |
|
| August 27, 2025 |
Certification Pursuant to Rule 13a-14(a) of the Exchange Act Exhibit 12.1 Certification Pursuant to Rule 13a-14(a) of the Exchange Act I, David Lontini, certify that: 1. I have reviewed this annual report on Form 20-F of Check-Cap Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements |
|
| August 27, 2025 |
February 25, 2025 to April 8, 2025 Exhibit 15.4 Sent via Electronic Delivery to: [email protected]; [email protected] April 9, 2025 Mr. David Lontini Chairman Check-Cap Ltd. Check-Cap Building Abba Hushi Avenue P.O. Box 1271 Isfiya, 3009000, Mount Carmel, Israel Re: Check-Cap Ltd. (the “Company”) Nasdaq Security: Ordinary Shares Nasdaq Symbol: CHEK Dear Mr. Lontini: As you know, our Listing Rules (the “Rules”) require l |
|
| August 27, 2025 |
Exhibit 4.34 LOAN AGREEMENT This Loan Agreement (this “Agreement”) dated as of December 23, 2024, is entered into among Nobul AI Corp. (the “Borrower”) and Check-Cap Ltd. (the “Lender”). WHEREAS, the Borrower and the Lender have entered into a business combination agreement dated March 25, 2024 (as amended, the “Business Combination Agreement”); and WHEREAS, the Business Combination Agreement prov |
|
| August 27, 2025 |
Exhibit 4.33 LOAN AGREEMENT This Loan Agreement (this “Agreement”) dated as of July 28, 2024, is entered into among Nobul AI Corp. (the “Borrower”) and Check-Cap Ltd. (the “Lender”). WHEREAS, the Borrower and the Lender have entered into a business combination agreement dated March 25, 2024 (as amended, the “Business Combination Agreement”); and WHEREAS, the Business Combination Agreement provides |
|
| August 27, 2025 |
Exhibit 15.6 By Electronic Delivery to: [email protected]; [email protected] May 21, 2025 Mr. David Lontini Chairman of the Board Check-Cap Ltd. Check-Cap Building 29 Abba Hushi Avenue P.O. Box 1271 Isfiya, 3009000, Mount Carmel, Israel Re: Check-Cap Ltd. (the “Company”) Nasdaq Symbol: CHEK Dear Mr. Lontini: Since your Company has not yet filed its From 20-F for the year ended December |
|
| August 27, 2025 |
Exhibit 4.36 LOAN AGREEMENT This Loan Agreement (this “Agreement”) dated as of July 3rd, 2025, is entered into among Apollo Technology Capital Corporation (the “Borrower”) and Check-Cap Ltd. (the “Lender”). WHEREAS, the Borrower and the Lender have entered into a business combination agreement dated March 25, 2024 (as amended, the “Business Combination Agreement”); and WHEREAS, the Business Combin |
|
| August 27, 2025 |
Check-Cap Ltd. Policy on Insider Trading Exhibit 11.1 Check-Cap Ltd. Policy on Insider Trading This Insider Trading Policy describes the standards of Check-Cap Ltd. and its subsidiaries (the “Company”) on trading, and causing the trading of, the Company’s securities or securities of certain other publicly traded companies while in possession of confidential information. This Policy is divided into two parts: the first part prohibits trad |
|
| August 27, 2025 |
Exhibit 15.2 Fahn Kanne & Co. Head Office 32 Hamasger Street Tel-Aviv 6721118, ISRAEL PO Box 36172, 6136101 T +972 3 7106666 F +972 3 7106660 www.gtfk.co.il CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We have issued our report dated May 15, 2024, with respect to the consolidated financial statements included in the Annual Report of Check Cap Ltd. on Form 20-F for the year ended Decemb |
|
| August 27, 2025 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 15.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in Registration Statements on Form S-8 (No. 333-203384, 333-226490 and 333-259666) and in Registration Statements on Form F-3 (No. 333-262401), of our report dated March 31, 2023, relating to the consolidated financial statements of Check-Cap Ltd. (the “Company”) appearing in this Ann |
|
| August 27, 2025 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 15.3 New York Office: 805 Third Avenue New York, NY 10022 212.838-5100 www.rbsmllp.com CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in Registration Statements on Form S-8 (No. 333-203384, 333-226490 and 333-259666) and in Registration Statements on Form F-3 (No. 333-262401), of our report dated August 26, 2025, relating to the consol |
|
| August 27, 2025 |
Exhibit 15.5 By Electronic Delivery to: [email protected]; [email protected] August 5, 2025 Mr. David Lontini Chairman of the Board Check-Cap Ltd. Check-Cap Building 29 Abba Hushi Avenue P.O. Box 1271 Isfiya, 3009000, Mount Carmel, Israel Re: Check-Cap Ltd. (the “Company”) Nasdaq Symbol: CHEK Dear Mr. Lontini: On May 21, 2025, Staff notified the Company that it did not comply with Nasd |
|
| August 27, 2025 |
Certification Pursuant to Rule 13a-14(a) of the Exchange Act Exhibit 12.2 Certification Pursuant to Rule 13a-14(a) of the Exchange Act I, Alan Lewis, certify that: 1. I have reviewed this annual report on Form 20-F of Check-Cap Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements we |
|
| August 27, 2025 |
U.S. Securities and Exchange Commission Exhibit 15.7 U.S. Securities and Exchange Commission Office of the Chief Accountant 100 F Street, NE Washington, DC 20549 USA Fahn Kanne & Co. Head Office 32 Hamasger Street Tel-Aviv 6721118, ISRAEL PO Box 36172, 6136101 T +972 3 7106666 Tel Aviv, August 26, 2025 F +972 3 7106660 9371/9557 www.gtfk.co.il Dear Sir or Madam: RE: Check-Cap Ltd. File No. 001-36848 We have read the statements made by C |
|
| August 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT O |
|
| August 27, 2025 |
Certification Pursuant to 18 U.S.C. Section 1350 Exhibit 13.1 Certification Pursuant to 18 U.S.C. Section 1350 Pursuant to U.S.C. Section 1350 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), each of the undersigned officers of Check-Cap Ltd. (the “Company”), does hereby certify, to such officer’s knowledge, that: The Annual Report on Form 20-F for the year ended December 31 |
|
| May 23, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For May, 2025 Commission File No. |
|
| May 1, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☒ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: December 31, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q For the Transition Pe |
|
| April 15, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For April, 2025 Commission File No. |
|
| December 31, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For December, 2024 Commission File No. |
|
| December 31, 2024 |
Exhibit 99.1 CHECK CAP LTD CONSOLIDATED UNAUDITED BALANCE SHEETS (U.S. dollars in thousands, except share and per share data) June 30, December 31, 2024 2023 Unaudited Audited Assets Current assets Cash and cash equivalents $ 17,824 $ 8,844 Short-term bank deposit - 15,912 Prepaid expenses and other current assets 130 100 Total current assets $ 17,954 24,856 Non-current assets Property and equipme |
|
| December 31, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For December, 2024 Commission File No. |
|
| December 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December, 2024 Commission File No. |
|
| December 3, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November, 2024 Commission File No. |
|
| September 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September, 2024 Commission File No. |
|
| August 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July, 2024 Commission File No. |
|
| May 15, 2024 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 15.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in Registration Statements on Form S-8 (No. 333-203384, 333-226490 and 333-259666) and in Registration Statements on Form F-3 (No. 333-262401), of our report dated March 31, 2023, relating to the consolidated financial statements of Check-Cap Ltd. (the “Company”) appearing in this Ann |
|
| May 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT O |
|
| May 15, 2024 |
Certification Pursuant to 18 U.S.C. Section 1350 Exhibit 13.1 Certification Pursuant to 18 U.S.C. Section 1350 Pursuant to U.S.C. Section 1350 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), each of the undersigned officers of Check-Cap Ltd. (the “Company”), does hereby certify, to such officer’s knowledge, that: The Annual Report on Form 20-F for the year ended December 31 |
|
| May 15, 2024 |
Check-Cap Ltd. COMPENSATION RECOVERY POLICY Exhibit 97.1 Check-Cap Ltd. COMPENSATION RECOVERY POLICY Check-Cap Ltd., an Israeli corporation (the “Company”), has adopted a Compensation Recovery Policy (this “Policy”) as described below. 1. Overview The Policy sets forth the circumstances and procedures under which the Company shall recover Erroneously Awarded Compensation from current and former Executive Officers of the Company in accordanc |
|
| May 15, 2024 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 15.2 Fahn Kanne & Co. Head Office 32 Hamasger Street Tel-Aviv 6721118, ISRAEL PO Box 36172, 6136101 T +972 3 7106666 F +972 3 7106660 www.gtfk.co.il CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We have issued our report dated May 15, 2024, with respect to the consolidated financial statements included in the Annual Report of Check Cap Ltd. on Form 20-F for the year ended Decemb |
|
| May 15, 2024 |
Certification Pursuant to Rule 13a-14(a) of the Exchange Act Exhibit 12.2 Certification Pursuant to Rule 13a-14(a) of the Exchange Act I, Iris Even-Tov, certify that: 1. I have reviewed this annual report on Form 20-F of Check-Cap Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements |
|
| May 15, 2024 |
Certification Pursuant to Rule 13a-14(a) of the Exchange Act Exhibit 12.1 Certification Pursuant to Rule 13a-14(a) of the Exchange Act I, Saar Levi, certify that: 1. I have reviewed this annual report on Form 20-F of Check-Cap Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements wer |
|
| May 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☒ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: December 31, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q For the Transition Pe |
|
| April 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April, 2024 Commission File No. |
|
| April 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April, 2024. Commission File Number: 001-36848 Check-Cap Ltd. (Exact Name of Registrant as Specified in Charter) Abba Hushi Avenue P.O. Box 1271 Isfiya, 30090 Mount Carmel, Israel (Address of p |
|
| April 15, 2024 |
Exhibit 99.1 Check-Cap Ltd. Check-Cap Building 29 Abba Hushi Avenue P.O. Box 1271 Isfiya, 3009000 Israel AMENDED NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS Dear Shareholder: On March 20, 2024, Check-Cap Ltd. (“Check-Cap,” the “Company,” “we,” or “our”) announced an Extraordinary General Meeting of Shareholders (the “Meeting”) to be held on April 25, 2024 at 9:00 a.m. (Eastern time). T |
|
| April 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K/A (Amendment No. 1) REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024. Commission File Number: 001-36848 Check-Cap Ltd. (Exact Name of Registrant as Specified in Charter) Abba Hushi Avenue P.O. Box 1271 Isfiya, 30090 Mount Carmel, I |
|
| April 10, 2024 |
Exhibit 16.1 April 10, 2024 Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549-7561 Dear Sirs/Madams: We have read the Form 6-K/A of Check-Cap Ltd. (the “Company”) dated April 10, 2024 regarding the Resignation of Registrant’s Certifying Accountant, and have the following comments: We agree with the statements made in paragraphs one, two, three and five, for which we have |
|
| April 8, 2024 |
Exhibit 10.1 SUPPORT AGREEMENT This SUPPORT AGREEMENT, dated as of April 5, 2024 (this “Agreement”), by and among EquityLine Alternate Assets GP Inc., a corporation incorporated under the laws of the Province of Ontario, Canada (“EquityLine”), Sergiy Shchavyelyev (“Sergiy”), the sole director of EquityLine and each of the other Check-Cap shareholders signatory hereto (each, a “Shareholder” and, co |
|
| April 8, 2024 |
CHEK / Check-Cap Ltd. / EquityLine Alternate Assets GP Inc. Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. 1)1 Check-Cap Ltd. (Name of Issuer) Ordinary Shares, par value NIS 48.00 (Title of Class of Securities) M2361E179 (CUSIP Number) EQUITYLINE ALTERNATE ASS |
|
| April 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024. Commission File Number: 001-36848 Check-Cap Ltd. (Exact Name of Registrant as Specified in Charter) Abba Hushi Avenue P.O. Box 1271 Isfiya, 30090 Mount Carmel, Israel (Address of pr |
|
| April 8, 2024 |
SUPPORT AGREEMENT This SUPPORT AGREEMENT, dated as of April 5, 2024 (this “Agreement”), by and among EquityLine Alternate Assets GP Inc. |
|
| April 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April, 2024. Commission File Number: 001-36848 Check-Cap Ltd. (Exact Name of Registrant as Specified in Charter) Abba Hushi Avenue P.O. Box 1271 Isfiya, 30090 Mount Carmel, Israel (Address of p |
|
| April 5, 2024 |
Exhibit 99.1 Check-Cap Ltd. Check-Cap Building 29 Abba Hushi Avenue P.O. Box 1271 Isfiya, 3009000 Israel AMENDED NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS Dear Shareholder: On March 20, 2024, Check-Cap Ltd. (“Check-Cap,” the “Company,” “we,” or “our”) announced an Extraordinary General Meeting of Shareholders (the “Meeting”) to be held on April 25, 2024 at 9:00 a.m. (Eastern time) at |
|
| April 1, 2024 |
CHEK / Check-Cap Ltd. / EquityLine Alternate Assets GP Inc. - THE SCHEDULE 13D Activist Investment SC 13D 1 sc13d1407100203292024.htm THE SCHEDULE 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a) (Amendment No. )1 Check-Cap Ltd. (Name of Issuer) Ordinary Shares, par value NIS 48.00 (Title of Class of Securities) |
|
| April 1, 2024 |
[Signature Page to the Coordination Agreement] EX-99.1 2 ex991to13d14071002032924.htm THE COORDINATION AGREEMENT Exhibit 99.1 THIS COORDINATION AGREEMENT, dated as of April 1, 2024 (this “Agreement”), is being entered into by and among EquityLine Alternate Assets GP Inc. (the “Investor”), on the one hand, and each of the undersigned shareholders (collectively, the “Shareholders”) of Check-Cap Ltd., an Israeli company (the “Company”). Each of t |
|
| April 1, 2024 |
EX-99.2 3 ex992to13d14071002032924.htm JOINT FILING AGREEMENT Exhibit 99.2 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including amendments thereto) with respect to the Ordinary Shares, par value NIS 48.00, of Check-C |
|
| March 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024. Commission File Number: 001-36848 Check-Cap Ltd. (Exact Name of Registrant as Specified in Charter) Abba Hushi Avenue P.O. Box 1271 Isfiya, 30090 Mount Carmel, Israel (Address of pr |
|
| March 28, 2024 |
Nobul AI Corp and Check-Cap Ltd Enter into Definitive Business Combination Agreement Exhibit 99.2 Nobul AI Corp and Check-Cap Ltd Enter into Definitive Business Combination Agreement Check-Cap Ltd. Mar 25, 2024, 19:15 ET Proposed business combination to create a North American technology company with an AI-driven fintech marketplace. Combined company to apply for listing on Nasdaq and TSX TORONTO, March 25, 2024 /CNW/ - Nobul AI Corp. (“Nobul”) and Check-Cap Ltd. (“Check-Cap” or t |
|
| March 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024. Commission File Number: 001-36848 Check-Cap Ltd. (Exact Name of Registrant as Specified in Charter) Abba Hushi Avenue P.O. Box 1271 Isfiya, 30090 Mount Carmel, Israel (Address of pr |
|
| March 28, 2024 |
NOBUL AI CORP. - AND - CHECK-CAP LTD. DATED AS OF MARCH 25, 2024 TABLE OF CONTENTS Exhibit 99.1 BUSINESS COMBINATION AGREEMENT BETWEEN NOBUL AI CORP. - AND - CHECK-CAP LTD. DATED AS OF MARCH 25, 2024 TABLE OF CONTENTS Article 1 DEFINITIONS AND INTERPRETATION 1 1.1 Certain Definitions. 1 1.2 Further Definitions. 14 1.3 Construction. 16 Article 2 TRANSACTIONS; CLOSING 17 2.1 Merger. 17 2.2 Closing; Effective Time. 17 2.3 Organizational Documents. 18 2.4 Directors and Officers. 18 |
|
| March 28, 2024 |
PROXY STATEMENT EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS Exhibit 99.1 PROXY STATEMENT EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS This Proxy Statement is furnished to our holders of ordinary shares, par value NIS 48.00 (the “Ordinary Shares”), in connection with Extraordinary General Meeting of Shareholders, to be held on April 25, 2024 at 9:00 a.m. (Eastern time) at the offices of Check-Cap’s United States legal counsel, Dorsey & Whitney LLP, 161 Bay |
|
| March 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024. Commission File Number: 001-36848 Check-Cap Ltd. (Exact Name of Registrant as Specified in Charter) Abba Hushi Avenue P.O. Box 1271 Isfiya, 30090 Mount Carmel, Israel (Address of pr |
|
| March 20, 2024 |
Exhibit 99.1 Check-Cap Ltd. Check-Cap Building 29 Abba Hushi Avenue P.O. Box 1271 Isfiya, 3009000 Israel NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS Dear Shareholder: We cordially invite you to attend an Extraordinary General Meeting of Shareholders (the “Meeting”) of Check-Cap Ltd. (“Check-Cap,” the “Company,” “we,” or “our”) to be held on April 25, 2024 at 9:00 a.m. (Eastern time) at |
|
| March 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024. Commission File Number: 001-36848 Check-Cap Ltd. (Exact Name of Registrant as Specified in Charter) Abba Hushi Avenue P.O. Box 1271 Isfiya, 30090 Mount Carmel, Israel (Address of pr |
|
| March 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024. Commission File Number: 001-36848 Check-Cap Ltd. (Exact Name of Registrant as Specified in Charter) Abba Hushi Avenue P.O. Box 1271 Isfiya, 30090 Mount Carmel, Israel (Address of pr |
|
| March 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024. Commission File Number: 001-36848 Check-Cap Ltd. (Exact Name of Registrant as Specified in Charter) Abba Hushi Avenue P.O. Box 1271 Isfiya, 30090 Mount Carmel, Israel (Address of pr |
|
| February 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For February 5, 2024 Commission File No. 001-36848 Check-Cap Ltd. Check-Cap Building Abba Hushi Avenue P.O. Box 1271 Isfiya, 30090 Mount Carmel, Israel (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) Indicate by check |
|
| January 24, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2024 (Report No. 3) Commission File Number: 001-36848 Check-Cap Ltd. Check-Cap Building Abba Hushi Avenue P.O Box 1271 Isfiya, 3009000, Mount Carmel, Israel (Address of principal execut |
|
| January 24, 2024 |
Exhibit 99.1 Graham Schmidt January 22, 2024 Paul Medeiros Chairman Check-Cap Ltd. Dear Mr. Paul Medeiros, I am writing to formally resign from the Board of Directors of Check-Cap Ltd effective January 22, 2024. After careful consideration I have decided to step down from my position, and I wish Check-Cap Ltd success. I wish to thank you for the privilege of serving, and I look forward to witnessi |
|
| January 11, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2024 (Report No. 2) Commission File Number: 001-36848 Check-Cap Ltd. Check-Cap Building Abba Hushi Avenue P.O Box 1271 Isfiya, 3009000, Mount Carmel, Israel (Address of principal execut |
|
| January 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2024 Commission File Number: 001-36848 Check-Cap Ltd. Check-Cap Building Abba Hushi Avenue P.O Box 1271 Isfiya, 3009000, Mount Carmel, Israel (Address of principal executive office) Ind |
|
| December 29, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For December 2023 (Report No. |
|
| December 18, 2023 |
Exhibit 99.5 Position Statement of Symetryx regarding rejecting the Keystone Transaction at the December 18, 2023 shareholders meeting. POSITION STATEMENT- LETTER FROM SYMETRYX CORPORATION TO ALL FELLOW CHECK-CAP SHAREHOLDERS 20.11.2023 Dear Fellow Check-Cap Shareholder, We are writing to you today on behalf of Symetryx Corporation (“Symetryx”) with regards to the notice of annual general meeting |
|
| December 18, 2023 |
NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS Exhibit 99.4 Notice of Extraordinary General Meeting of Shareholders from Symetryx, dated October 30, 2023, as a result of inaction from Issuer’s Board of Directors following the above Exhibit 99.3. NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS Dear Shareholder: On September 29, 2023, Symetryx Corp. (“Symetryx”, or the “Proposing Shareholder”), requested the board of directors (the “Boar |
|
| December 18, 2023 |
Exhibit 99.3 Symetryx Letter to Issuer’s Board of Directors, dated September 29, 2023, demanding a Special Meeting of Shareholders to remove and replace Directors. Symetryx Corporation September 29, 2023 Check-Cap Ltd. 29 Abba Hushi Avenue, P.O. Box 1271 Isfiya 3009000, Israel Attention: The Board of Directors of Check-Cap Ltd.; Mr. Steven Hanley, Chairman of the Board of Directors; Mr. Alex Ovadi |
|
| December 18, 2023 |
Purchases by Symetryx of Issuer Common Stock in the Past Sixty Days. Exhibit 99.1 Purchases by Symetryx of Issuer Common Stock in the Past Sixty Days. All of the purchases of Issuer Common Stock were made by Symetryx on the Nasdaq Stock Market. Trade Date Number of Shares Trade Price June 16, 2023 93 $ 2.470 June 16, 2023 4807 $ 2.480 June 16, 2023 100 $ 2.470 June 20, 2023 1000 $ 2.700 June 20, 2023 3077 $ 2.690 June 20, 2023 100 $ 2.730 June 20, 2023 823 $ 2.740 |
|
| December 18, 2023 |
CHEK / Check-Cap Ltd. / Symetryx Corp - AMENDMENT NO. 4 TO SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION, Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4)* Check-Cap LTD (Name of Issuer) Ordinary Shares, par value NIS 48.00 (Title of Class of Securities) M2361E179 (CUSIP Number) Barry Shiff, 2828 Bathurst Street, Suite 400, Toronto, Canada M6B-3A7, 416-453-7832 (Name, Address and Telephone Number of Person |
|
| December 18, 2023 |
Exhibit 99.2 Power of Attorney of Symetryx Authorizing Legal Counsel to Cause this Schedule 13D to be filed with the Securities and Exchange Commission LIMITED POWER OF ATTORNEY FOR FILINGS UNDER THE SECURITIES ACT OF 1933, AS AMENDED AND THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED Know all by these presents, that the undersigned hereby constitutes and appoints Cynthia Libby, Michael Bluestein |
|
| December 18, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For December 2023 Commission File No. |
|
| December 18, 2023 |
CORRECTION OF A CLERICAL ERROR EXHIBIT 99.6 PRESS RELEASE OF DECEMBER 13, 2023 FROM SYMETRYX AND A CLERICAL CORRECTION DATED DECEMBER 18, 2023. CHECK- CAP BOARD MEMBER’S STATEMENT ON THE STAND SUGGESTS A POTENTIAL CONFLICT OF INTEREST WITH KEYSTONE DENTAL SYMETRYX RECOMMENDS VOTING AGAINST THE KEYSTONE DENTAL MERGER SYMETRYX RECOMMENDS VOTING FOR THEIR QUALIFIED INDEPENDENT BOARD NOMINEES TIME IS SHORT - THE VOTE DEADLINE IS 11 |
|
| December 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For December 2023 Commission File No. |
|
| December 15, 2023 |
Check-Cap Board of Directors Issues Letter to Shareholders Exhibit 99.1 Check-Cap Board of Directors Issues Letter to Shareholders ISFIYA, Israel, December 14, 2023 (GLOBE NEWSWIRE) – Check-Cap, Ltd. (the “Company” or “Check-Cap”) (NASDAQ: CHEK) today issued the following letter from its Board of Directors to its shareholders and to the investment community: Dear Check-Cap Shareholders, The Board of Directors wishes to inform shareholders and the broader |
|
| December 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For December 2023 Commission File No. |
|
| December 7, 2023 |
Exhibit 99.1 Leading Independent Proxy Advisory Firm ISS Recommends Check-Cap Shareholders Vote FOR the Keystone Dental Business Combination Agreement ISS recommends voting FOR the re-election of Check-Cap’s director nominees and AGAINST the election of the director nominees put forth by Symetryx ISS recommends approval of the authorization of Check-Cap’s board of directors to effect a reverse sha |
|
| December 7, 2023 |
425 Filed by Capstone Dental Pubco, Inc. Pursuant to Rule 425 under the Securities Act of 1933 Subject Companies: Check-Cap Ltd. (Commission File No.: 001-36848) Keystone Dental Holdings, Inc. Date: December 7, 2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1 |
|
| December 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For December 2023 Commission File No. |
|
| December 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For December 2023 Commission File No. |
|
| November 28, 2023 |
Filed by Capstone Dental Pubco, Inc. Pursuant to Rule 425 under the Securities Act of 1933 Subject Companies: Check-Cap Ltd. (Commission File No.: 001-36848) Keystone Dental Holdings, Inc. Date: November 28, 2023 Keystone Dental Reports Third Quarter 2023 Financial Results and Provides a Corporate Update Q3 revenue increased 18.9% year-over-year to $16.8M, including $11.9M from the U.S. Check-Cap |
|
| November 28, 2023 |
Filed by Capstone Dental Pubco, Inc. Pursuant to Rule 425 under the Securities Act of 1933 Subject Companies: Check-Cap Ltd. (Commission File No.: 001-36848) Keystone Dental Holdings, Inc. Date: November 28, 2023 Keystone Dental Reports Third Quarter 2023 Financial Results and Provides a Corporate Update Q3 revenue increased 18.9% year-over-year to $16.8M, including $11.9M from the U.S. Check-Cap |
|
| November 28, 2023 |
Filed by Capstone Dental Pubco, Inc. Pursuant to Rule 425 under the Securities Act of 1933 Subject Companies: Check-Cap Ltd. (Commission File No.: 001-36848) Keystone Dental Holdings, Inc. Date: November 28, 2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 |
|
| November 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For November 2023 Commission File No. |
|
| November 27, 2023 |
CHEK / Check-Cap Ltd / Symetryx Corp - AMENDMENT NO. 3 TO SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION, Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)* Check-Cap LTD (Name of Issuer) Ordinary Shares, par value NIS 48.00 (Title of Class of Securities) M2361E179 (CUSIP Number) Barry Shiff, 2828 Bathurst Street, Suite 400, Toronto, Canada M6B-3A7, 416-453-7832 (Name, Address and Telephone Number of Person |
|
| November 27, 2023 |
Purchases by Symetryx of Issuer Common Stock in the Past Sixty Days. Exhibit 99.1 Purchases by Symetryx of Issuer Common Stock in the Past Sixty Days. All of the purchases of Issuer Common Stock were made by Symetryx on the Nasdaq Stock Market. Trade Date Number of Shares Trade Price June 16, 2023 93 $ 2.470 June 16, 2023 4807 $ 2.480 June 16, 2023 100 $ 2.470 June 20, 2023 1000 $ 2.700 June 20, 2023 3077 $ 2.690 June 20, 2023 100 $ 2.730 June 20, 2023 823 $ 2.740 |
|
| November 27, 2023 |
Exhibit 99.2 Power of Attorney of Symetryx Authorizing Legal Counsel to Cause this Schedule 13D to be filed with the Securities and Exchange Commission LIMITED POWER OF ATTORNEY FOR FILINGS UNDER THE SECURITIES ACT OF 1933, AS AMENDED AND THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED Know all by these presents, that the undersigned hereby constitutes and appoints Cynthia Libby, Michael Bluestein |
|
| November 27, 2023 |
Check-Cap Reports Third Quarter 2023 Financial Results and Provides a Corporate Update Exhibit 99.1 Check-Cap Reports Third Quarter 2023 Financial Results and Provides a Corporate Update Check-Cap shareholders to vote on proposed Business Combination Agreement with Keystone Dental at Annual General Meeting on Monday, December 18th ISFIYA, Israel, Nov. 27, 2023 /PRNewswire/ - Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), today announced financial results and provided |
|
| November 27, 2023 |
EX-99.5 6 ea189081ex99-5check.htm POSITION STATEMENT OF SYMETRYX REGARDING REJECTING THE KEYSTONE TRANSACTION AT THE DECEMBER 18, 2023 SHAREHOLDERS MEETING Exhibit 99.5 Position Statement of Symetryx regarding rejecting the Keystone Transaction at the December 18, 2023 shareholders meeting. POSITION STATEMENT- LETTER FROM SYMETRYX CORPORATION TO ALL FELLOW CHECK-CAP SHAREHOLDERS 20.11.2023 Dear Fe |
|
| November 27, 2023 |
EX-99.3 4 ea189081ex99-3check.htm LETTER FROM SYMETRYX TO ISSUER'S BOARD OF DIRECTORS, DATED SEPTEMBER 29, 2023, DEMANDING A SPECIAL MEETING OF SHAREHOLDERS TO REMOVE AND REPLACE DIRECTORS Exhibit 99.3 Symetryx Letter to Issuer’s Board of Directors, dated September 29, 2023, demanding a Special Meeting of Shareholders to remove and replace Directors. Symetryx Corporation September 29, 2023 Check-C |
|
| November 27, 2023 |
NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS EX-99.4 5 ea189081ex99-4check.htm NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS FROM SYMETRYX, DATED OCTOBER 30, 2023, AS A RESULT OF INACTION FROM ISSUER'S BOARD OF DIRECTORS FOLLOWING THE ABOVE EXHIBIT 99.3 Exhibit 99.4 Notice of Extraordinary General Meeting of Shareholders from Symetryx, dated October 30, 2023, as a result of inaction from Issuer’s Board of Directors following the ab |
|
| November 24, 2023 |
Table of Contents Filed by Capstone Dental Pubco, Inc. Pursuant to Rule 425 under the Securities Act of 1933 Subject Companies: Check-Cap Ltd. (Commission File No.: 001-36848) Keystone Dental Holdings, Inc. Date: November 22, 2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EX |
|
| November 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For November 2023 Commission File No. |
|
| November 22, 2023 |
Exhibit 99.1 Dear Shareholder: Your vote is important! We urge you to vote “FOR” Check-Cap’s Business Combination Agreement with Keystone Dental Holdings Inc. (“Keystone”) and “FOR” the election of the Company Director Nominees. The Business Combination has been unanimously (with one director absent) approved and recommended by the Check-Cap board of directors and unanimously approved by the Keyst |
|
| November 22, 2023 |
Exhibit 99.2 Check-Cap Ltd. Check-Cap Building 29 Abba Hushi Avenue P.O. Box 1271 Isfiya, 3009000 Israel PROXY STATEMENT ANNUAL GENERAL MEETING OF SHAREHOLDERS This Proxy Statement is being furnished in connection with the solicitation of proxies on behalf of the board of directors of Check-Cap Ltd. (“we,” “us,” “our,” “Check-Cap” or the “Company”) to be voted at an Annual General Meeting of Share |
|
| November 22, 2023 |
POSITION STATEMENT- LETTER FROM SYMETRYX CORPORATION TO ALL FELLOW CHECK-CAP SHAREHOLDERS Exhibit 99.4 POSITION STATEMENT- LETTER FROM SYMETRYX CORPORATION TO ALL FELLOW CHECK-CAP SHAREHOLDERS 20.11.2023 Dear Fellow Check-Cap Shareholder, We are writing to you today on behalf of Symetryx Corporation (“Symetryx”) with regards to the notice of annual general meeting of shareholders filed on 13.11.2023 by Check-Cap Ltd. (“Check-Cap”) and Check-Cap upcoming annual general meeting scheduled |
|
| November 22, 2023 |
CHECK-CAP LTD. THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS Exhibit 99.3 CHECK-CAP LTD. THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS The undersigned hereby appoint(s) Alex Ovadia and Mira Rosenzweig, or either of them, attorneys or attorney of the undersigned, for and in the name(s) of the undersigned, with power of substitution and revocation in each to vote any and all ordinary shares, par value NIS 48.00 per share, of Check-Cap Ltd. (the |
|
| November 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For November 2023 Commission File No. |
|
| November 14, 2023 |
Filed by Capstone Dental Pubco, Inc. Pursuant to Rule 425 under the Securities Act of 1933 Subject Companies: Check-Cap Ltd. (Commission File No.: 001-36848) Keystone Dental Holdings, Inc. Date: November 13, 2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 |
|
| November 14, 2023 |
CHEK / Check-Cap Ltd / Symetryx Corp - AMENDMENT NO. 2 TO SCHEDULE 13D Activist Investment SC 13D/A 1 ea188288-13da2symetryxcheck.htm AMENDMENT NO. 2 TO SCHEDULE 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION, Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* Check-Cap LTD (Name of Issuer) Ordinary Shares, par value NIS 48.00 (Title of Class of Securities) M2361E179 (CUSIP Number) Barry Shiff, 2828 Bathurst Street, Suite 400, Toronto, |
|
| November 14, 2023 |
Exhibit 99.3 Symetryx Letter to Issuer’s Board of Directors, dated September 29, 2023, demanding a Special Meeting of Shareholders to remove and replace Directors. Symetryx Corporation September 29, 2023 Check-Cap Ltd. 29 Abba Hushi Avenue, P.O. Box 1271 Isfiya 3009000, Israel Attention: The Board of Directors of Check-Cap Ltd.; Mr. Steven Hanley, Chairman of the Board of Directors; Mr. Alex Ovadi |
|
| November 14, 2023 |
Exhibit 99.2 Power of Attorney of Symetryx Authorizing Legal Counsel to Cause this Schedule 13D to be filed with the Securities and Exchange Commission LIMITED POWER OF ATTORNEY FOR FILINGS UNDER THE SECURITIES ACT OF 1933, AS AMENDED AND THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED Know all by these presents, that the undersigned hereby constitutes and appoints Cynthia Libby, Michael Bluestein |
|
| November 14, 2023 |
NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS Exhibit 99.4 Notice of Extraordinary General Meeting of Shareholders from Symetryx, dated October 30, 2023, as a result of inaction from Issuer’s Board of Directors following the above Exhibit 99.3. NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS Dear Shareholder: On September 29, 2023, Symetryx Corp. (“Symetryx”, or the “Proposing Shareholder”), requested the board of directors (the “Boar |
|
| November 14, 2023 |
Purchases by Symetryx of Issuer Common Stock in the Past Sixty Days. EXHIBIT 99.1 Purchases by Symetryx of Issuer Common Stock in the Past Sixty Days. All of the purchases of Issuer Common Stock were made by Symetryx on the Nasdaq Stock Market. Trade Date Number of Shares Trade Price June 16, 2023 93 $ 2.470 June 16, 2023 4807 $ 2.480 June 16, 2023 100 $ 2.470 June 20, 2023 1000 $ 2.700 June 20, 2023 3077 $ 2.690 June 20, 2023 100 $ 2.730 June 20, 2023 823 $ 2.740 |
|
| November 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For November 2023 Commission File No. |
|
| November 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For November 2023 Commission File No. |
|
| November 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For November 2023 Commission File No. |
|
| November 13, 2023 |
Exhibit 99.1 Check-Cap Ltd. Check-Cap Building 29 Abba Hushi Avenue P.O. Box 1271 Isfiya, 3009000 Israel NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS Dear Shareholder: We cordially invite you to attend the Annual General Meeting of Shareholders (the “Meeting”) of Check-Cap Ltd. (“Check-Cap,” the “Company,” “we,” “us” or “our”) to be held on Monday, December 18, 2023 at 2:00 p.m. (Israel time) |
|
| November 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For November 2023 Commission File No. |
|
| November 1, 2023 |
Exhibit 99.1 Check-Cap Ltd. Check-Cap Building 29 Abba Hushi Avenue P.O. Box 1271 Isfiya, 3009000 Israel NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS Dear Shareholder: We cordially invite you to attend an Extraordinary General Meeting of Shareholders (the “Meeting”) of Check-Cap Ltd. (“Check-Cap,” the “Company,” “we,” “us” or “our”) to be held on Monday, December 4, 2023 at 2:00 p.m. (I |
|
| November 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For October 2023 Commission File No. |
|
| October 30, 2023 |
Exhibit 99.2 Power of Attorney of Symetryx Authorizing Legal Counsel to Cause this Schedule 13D to be filed with the Securities and Exchange Commission LIMITED POWER OF ATTORNEY FOR FILINGS UNDER THE SECURITIES ACT OF 1933, AS AMENDED AND THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED Know all by these presents, that the undersigned hereby constitutes and appoints Cynthia Libby, Michael Bluestein |
|
| October 30, 2023 |
NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS Exhibit 99.4 Notice of Extraordinary General Meeting of Shareholders from Symetryx, dated October 30, 2023, as a result of inaction from Issuer’s Board of Directors following the above Exhibit 99.3. NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS Dear Shareholder: On September 29, 2023, Symetryx Corp. (“Symetryx”, or the “Proposing Shareholder”), requested the board of directors (the “Boar |
|
| October 30, 2023 |
Exhibit 99.3 Symetryx Letter to Issuer’s Board of Directors, dated September 29, 2023, demanding a Special Meeting of Shareholders to remove and replace Directors. Symetryx Corporation September 29, 2023 Check-Cap Ltd. 29 Abba Hushi Avenue, P.O. Box 1271 Isfiya 3009000, Israel Attention: The Board of Directors of Check-Cap Ltd.; Mr. Steven Hanley, Chairman of the Board of Directors; Mr. Alex Ovadi |
|
| October 30, 2023 |
Purchases by Symetryx of Issuer Common Stock in the Past Sixty Days. Exhibit 99.1 Purchases by Symetryx of Issuer Common Stock in the Past Sixty Days. All of the purchases of Issuer Common Stock were made by Symetryx on the Nasdaq Stock Market. Trade Date Number of Shares Trade Price June 16, 2023 93 $ 2.470 June 16, 2023 4807 $ 2.480 June 16, 2023 100 $ 2.470 June 20, 2023 1000 $ 2.700 June 20, 2023 3077 $ 2.690 June 20, 2023 100 $ 2.730 June 20, 2023 823 $ 2.740 |
|
| October 30, 2023 |
CHEK / Check-Cap Ltd / Symetryx Corp - AMENDMENT NO. 1 TO SCHEDULE 13D Activist Investment SC 13D/A 1 ea187439-13da1symetryxcheck.htm AMENDMENT NO. 1 TO SCHEDULE 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION, Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Check-Cap LTD (Name of Issuer) Ordinary Shares, par value NIS 48.00 (Title of Class of Securities) M2361E179 (CUSIP Number) Barry Shiff, 2828 Bathurst Street, Suite 400, Toronto, |
|
| October 30, 2023 |
Filed by Capstone Dental Pubco, Inc. Pursuant to Rule 425 under the Securities Act of 1933 Subject Companies: Check-Cap Ltd. (Commission File No.: 001-36848) Keystone Dental Holdings, Inc. Date: October 27, 2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 |
|
| October 27, 2023 |
Check-Cap Issues Letter to Shareholders Regarding Proposed Merger with Keystone Dental Holdings Exhibit 99.1 Check-Cap Issues Letter to Shareholders Regarding Proposed Merger with Keystone Dental Holdings ISFYIA, Israel, October 19, 2023 (GLOBE NEWSWIRE) - Check-Cap Ltd. (the “Company” or “Check-Cap”) (NASDAQ: CHEK), today issued the following letter from its Board of Directors to its shareholders and to the investment community: Dear Check-Cap Shareholders, In the months since Check-Cap ann |
|
| October 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For October 2023 Commission File No. |
|
| October 20, 2023 |
Check-Cap Issues Letter to Shareholders Regarding Proposed Merger with Keystone Dental Holdings Exhibit 99.1 Check-Cap Issues Letter to Shareholders Regarding Proposed Merger with Keystone Dental Holdings ISFYIA, Israel, October 19, 2023 (GLOBE NEWSWIRE) - Check-Cap Ltd. (the “Company” or “Check-Cap”) (NASDAQ: CHEK), today issued the following letter from its Board of Directors to its shareholders and to the investment community: Dear Check-Cap Shareholders, In the months since Check-Cap ann |
|
| October 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For October 2023 Commission File No. |
|
| September 29, 2023 |
Purchases by Symetryx of Issuer Common Stock in the Past Sixty Days. Exhibit 99.1 Purchases by Symetryx of Issuer Common Stock in the Past Sixty Days. All of the purchases of Issuer Common Stock were made by Symetryx on the Nasdaq Stock Market. Trade Date Number of Shares Trade Price June 16, 2023 93 $ 2.470 June 16, 2023 4807 $ 2.480 June 16, 2023 100 $ 2.470 June 20, 2023 1000 $ 2.700 June 20, 2023 3077 $ 2.690 June 20, 2023 100 $ 2.730 June 20, 2023 823 $ 2.740 |
|
| September 29, 2023 |
CHEK / Check-Cap Ltd / Symetryx Corp - SCHEDULE 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION, Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No.)* Check-Cap LTD (Name of Issuer) Ordinary Shares, par value NIS 48.00 (Title of Class of Securities) M2361E179 (CUSIP Number) Barry Shiff, 2828 Bathurst Street, Suite 400, Toronto, Canada M6B-3A7, 416-453-7832 (Name, Address and Telephone Number of Person A |
|
| September 29, 2023 |
Exhibit 99.2 Power of Attorney of Symetryx Authorizing Legal Counsel to Cause this Schedule 13D to be filed with the Securities and Exchange Commission LIMITED POWER OF ATTORNEY FOR FILINGS UNDER THE SECURITIES ACT OF 1933, AS AMENDED AND THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED Know all by these presents, that the undersigned hereby constitutes and appoints Cynthia Libby, Michael Bluestein |
|
| September 29, 2023 |
Exhibit 99.3 Symetryx Letter to Issuer’s Board of Directors, dated September 29, 2023, demanding a Special Meeting of Shareholders to remove and replace Directors. Symetryx Corporation September 29, 2023 Check-Cap Ltd. 29 Abba Hushi Avenue, P.O. Box 1271 Isfiya 3009000, Israel Attention: The Board of Directors of Check-Cap Ltd.; Mr. Steven Hanley, Chairman of the Board of Directors; Mr. Alex Ovadi |
|
| September 22, 2023 |
CHEK / Check-Cap Ltd / Ramanathan Vijay - 13G Passive Investment SC 13G 1 20030920chek13g.htm 13G SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT N0. ) Check-Cap Ltd. (Name of Issuer) Ordinary Shares, par value NIS 48.00 (Title of Class of Securities) M2361E179 (CUSIP Number) September 13, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate |
|
| August 17, 2023 |
Exhibit 99.3 LOCK-UP AGREEMENT August 16, 2023 Capstone Dental Pubco, Inc. 154 Middlesex Turnpike Burlington, MA 01803 Ladies and Gentlemen: The undersigned signatory of this lock-up agreement (this “Lock-Up Agreement”) understands that Capstone Dental Pubco, Inc. (the “Company”), a Delaware corporation, has entered into a Business Combination Agreement, dated as of the date hereof (as the same ma |
|
| August 17, 2023 |
Exhibit 99.2 STOCKHOLDER SUPPORT AGREEMENT This STOCKHOLDER SUPPORT AGREEMENT, dated as of August 16, 2023 (this “Agreement”), by and among Keystone Dental Holdings, Inc., a Delaware corporation (“Keystone”), Check-Cap Ltd., an Israeli company (“Check-Cap”), and certain of the stockholders of Keystone whose names appear on the signature pages of this Agreement (each, a “Stockholder” and, collectiv |
|
| August 17, 2023 |
Exhibit 99.3 LOCK-UP AGREEMENT August 16, 2023 Capstone Dental Pubco, Inc. 154 Middlesex Turnpike Burlington, MA 01803 Ladies and Gentlemen: The undersigned signatory of this lock-up agreement (this “Lock-Up Agreement”) understands that Capstone Dental Pubco, Inc. (the “Company”), a Delaware corporation, has entered into a Business Combination Agreement, dated as of the date hereof (as the same ma |
|
| August 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Filed by Check-Cap Ltd. Pursuant to Rule 425 under the Securities Act of 1933 Subject Companies: Check-Cap Ltd. Keystone Dental Holdings, Inc. Commission File No.: 001-36848 Date: August 17, 2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For August 2023 |
|
| August 17, 2023 |
Exhibit 99.5 Management Presentation August 2023 1 Forward Looking Statements Certain statements in this Presentation may constitute “forward-looking statements”. Forward-looking statements include, but are not limited to, statements regarding expectations, hopes, beliefs, intentions or strategies of Check-Cap Ltd. (“Check-Cap”) and/or Keystone Dental Holdings, Inc. (“Keystone”) regarding the futu |
|
| August 17, 2023 |
Filed by Capstone Dental Pubco, Inc. Pursuant to Rule 425 under the Securities Act of 1933 Subject Companies: Check-Cap Ltd. (Commission File No.: 001-36848) Keystone Dental Holdings, Inc. Date: August 17, 2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 F |
|
| August 17, 2023 |
Exhibit 99.1 BUSINESS COMBINATION AGREEMENT among KEYSTONE DENTAL HOLDINGS, INC., CAPSTONE DENTAL PUBCO, INC., CAPSTONE MERGER SUB LTD., CAPSTONE MERGER SUB CORP., and CHECK-CAP LTD. Dated as of August 16, 2023 TABLE OF CONTENTS Page Section 1. DEFINITIONS AND INTERPRETATION 3 1.1 Certain Definitions 3 1.2 Further Definitions 15 1.3 Construction 18 Section 2. TRANSACTIONS; CLOSING. 19 2.1 Israeli |
|
| August 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For August 2023 Commission File No. |
|
| August 17, 2023 |
Exhibit 99.1 BUSINESS COMBINATION AGREEMENT among KEYSTONE DENTAL HOLDINGS, INC., CAPSTONE DENTAL PUBCO, INC., CAPSTONE MERGER SUB LTD., CAPSTONE MERGER SUB CORP., and CHECK-CAP LTD. Dated as of August 16, 2023 TABLE OF CONTENTS Page Section 1. DEFINITIONS AND INTERPRETATION 3 1.1 Certain Definitions 3 1.2 Further Definitions 15 1.3 Construction 18 Section 2. TRANSACTIONS; CLOSING. 19 2.1 Israeli |
|
| August 17, 2023 |
Exhibit 99.5 Management Presentation August 2023 1 Forward Looking Statements Certain statements in this Presentation may constitute “forward-looking statements”. Forward-looking statements include, but are not limited to, statements regarding expectations, hopes, beliefs, intentions or strategies of Check-Cap Ltd. (“Check-Cap”) and/or Keystone Dental Holdings, Inc. (“Keystone”) regarding the futu |
|
| August 17, 2023 |
Exhibit 99.4 Keystone Dental Holdings and Check-Cap Ltd Enter into Definitive Business Combination Agreement Proposed business combination to create a Nasdaq-listed medical device company focused on advancing the commercial execution and market development of Keystone’s comprehensive portfolio of implants, arches and other tooth replacement solutions Keystone 2022 revenues exceeded $60 million The |
|
| August 17, 2023 |
Exhibit 99.4 Keystone Dental Holdings and Check-Cap Ltd Enter into Definitive Business Combination Agreement Proposed business combination to create a Nasdaq-listed medical device company focused on advancing the commercial execution and market development of Keystone’s comprehensive portfolio of implants, arches and other tooth replacement solutions Keystone 2022 revenues exceeded $60 million The |
|
| August 17, 2023 |
Exhibit 99.2 STOCKHOLDER SUPPORT AGREEMENT This STOCKHOLDER SUPPORT AGREEMENT, dated as of August 16, 2023 (this “Agreement”), by and among Keystone Dental Holdings, Inc., a Delaware corporation (“Keystone”), Check-Cap Ltd., an Israeli company (“Check-Cap”), and certain of the stockholders of Keystone whose names appear on the signature pages of this Agreement (each, a “Stockholder” and, collectiv |
|
| August 4, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For August 2023 Commission File No. |
|
| August 4, 2023 |
Check-Cap Reports Second Quarter 2023 Financial Results Exhibit 99.1 Check-Cap Reports Second Quarter 2023 Financial Results ISFIYA, Israel, August 4, 2023 - Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), today announced financial results for the second quarter and six months ended June 30, 2023. Financial Results for the Second Quarter Ended June 30, 2023 Research and development expenses, net, were $4.5 million for the three months end |
|
| August 4, 2023 |
Exhibit 99.2 CHECK CAP LTD. CONSOLIDATED UNAUDITED FINANCIAL STATEMENTS AS OF JUNE 30, 2023 CHECK CAP LTD. CONSOLIDATED UNAUDITED FINANCIAL STATEMENTS AS OF JUNE 30, 2023 Table of Contents Page Financial Statements: Consolidated Unaudited Balance Sheets 3 Consolidated Unaudited Statements of Comprehensive Loss 4 Consolidated Unaudited Statements of Changes in Shareholders Equity 5 Consolidated Una |
|
| June 6, 2023 |
Check-Cap Announces Review of Strategic Alternatives and Reduction in Workforce Exhibit 99.1 Check-Cap Announces Review of Strategic Alternatives and Reduction in Workforce ISFIYA, Israel, June 6, 2023 - Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) today announced that following a review of its business, resources and capabilities, it is exploring strategic alternatives focused on maximizing stockholder value. As part of this process, the Company has engaged L |
|
| June 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For June 2023 Commission File No. |
|
| May 11, 2023 |
Check-Cap Reports First Quarter 2023 Financial Results Exhibit 99.1 Check-Cap Reports First Quarter 2023 Financial Results ISFIYA, Israel, May 11, 2023 - Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and only patient-friendly, preparation-free screening test to detect polyps before they may transform into colorectal cancer (CRC), today announce |
|
| May 11, 2023 |
6-K 1 zk2329720.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For May 2023 Commission File No. 001-36848 Check-Cap Ltd. Check-Cap Building Abba Hushi Avenue P.O. Box 1271 Isfiya, 3009000, Israel (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES.) Indicate by c |
|
| March 31, 2023 |
Certification of Chief Financial Officer Pursuant to Rule 13a-14(a)/15d-14(a) Exhibit 12.2 Certification Pursuant to Rule 13a-14(a) of the Exchange Act I, Mira Rosenzweig, certify that: 1. I have reviewed this annual report on Form 20-F of Check-Cap Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statemen |
|
| March 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT O |
|
| March 31, 2023 |
Certification of Chief Executive Officer Pursuant to Rule 13a-14(a)/15d-14(a) Exhibit 12.1 Certification Pursuant to Rule 13a-14(a) of the Exchange Act I, Alex Ovadia, certify that: 1. I have reviewed this annual report on Form 20-F of Check-Cap Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements w |
|
| March 31, 2023 |
Check-Cap Reports Fourth Quarter and Full Year 2022 Financial Results Exhibit 99.1 Check-Cap Reports Fourth Quarter and Full Year 2022 Financial Results ISFIYA, Israel, March 31, 2023 - Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and only patient-friendly, preparation-free screening test to detect polyps before they may transform into color |
|
| March 31, 2023 |
Exhibit 13.1 Certification Pursuant to 18 U.S.C. Section 1350 Pursuant to U.S.C. Section 1350 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), each of the undersigned officers of Check- Cap Ltd. (the “Company”), does hereby certify, to such officer’s knowledge, that: The Annual Report on Form 20-F for the year ended December 3 |
|
| March 31, 2023 |
eExhibit 15.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in Registration Statements on Form S-8 (No. 333-203384, 333-226490 and 333-259666) and in Registration Statements on Form F-3 (No. 333-211065, 333-225789, 333-248200 and 333-262401), of our report dated March 31, 2023, relating to the financial statements of Check-Cap Ltd. (the “Comp |
|
| March 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For March 2023 Commission File No. |
|
| March 31, 2023 |
Amended and Restated Articles of Association of the Registrant Exhibit 1.1 THE COMPANIES LAW, 5759-1999 A LIMITED LIABILITY COMPANY ARTICLES OF ASSOCIATION OF CHECK-CAP LTD. Preliminary 1. Definitions; Interpretation (a) In these Articles, the following terms (whether or not capitalized) shall bear the meanings set forth opposite them, respectively, unless the subject or context requires otherwise: “Articles” shall mean these Articles of Association, as amend |
|
| March 21, 2023 |
Check-Cap Issues an Update to Shareholders Exhibit 99.1 Check-Cap Issues an Update to Shareholders ISFIYA, Israel, March 21, 2023 - Check-Cap Ltd. (the “Company” or “Check-Cap”) (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and only patient-friendly bowel prep-free screening test to detect polyps before they may transform into colorectal cancer (CRC), today iss |
|
| March 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 6-K 1 zk2329418.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For March 2023 Commission File No. 001-36848 Check-Cap Ltd. Check-Cap Building Abba Hushi Avenue P.O. Box 1271 Isfiya, 3009000, Israel (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES.) Indicate by |
|
| December 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For December 2022 Commission File No. |
|
| December 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For December 2022 Commission File No. |
|
| November 30, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For November 2022 Commission File No. |
|
| November 30, 2022 |
Check-Cap Reports Third Quarter 2022 Financial Results and Provides a Corporate Update Exhibit 99.1 Check-Cap Reports Third Quarter 2022 Financial Results and Provides a Corporate Update ISFIYA, Israel, November 30, 2022 - Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and only patient-friendly, preparation-free screening test to detect polyps before they may |
|
| November 23, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For November 2022 Commission File No. |
|
| November 9, 2022 |
CHECK-CAP LTD. THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS Exhibit 99.2 CHECK-CAP LTD. THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS The undersigned hereby appoint(s) Alex Ovadia and Mira Rosenzweig, or either of them, attorneys or attorney of the undersigned, for and in the name(s) of the undersigned, with power of substitution and revocation in each to vote any and all ordinary shares, par value NIS 2.40 per share, of Check-Cap Ltd. (the “ |
|
| November 9, 2022 |
Exhibit 99.1 Check-Cap Ltd. Check-Cap Building 29 Abba Hushi Avenue P.O. Box 1271 Isfiya, 3009000 Israel NOTICE OF 2022 ANNUAL GENERAL MEETING OF SHAREHOLDERS Dear Shareholder: We cordially invite you to attend the 2022 Annual General Meeting of Shareholders of Check-Cap Ltd. (the “Meeting”) to be held on Thursday, December 22, 2022, at 4:00 p.m. (Israel time) at our offices at the Check-Cap Build |
|
| November 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For November 2022 Commission File No. |
|
| August 31, 2022 |
Exhibit 99.2 CHECK CAP LTD. CONSOLIDATED UNAUDITED FINANCIAL STATEMENTS AS OF JUNE 30, 2022 CHECK CAP LTD. CONSOLIDATED UNAUDITED FINANCIAL STATEMENTS AS OF JUNE 30, 2022 Table of Contents Page Financial Statements: Consolidated Unaudited Balance Sheets 3 Consolidated Unaudited Statements of Comprehensive Loss 4 Consolidated Unaudited Statements of Changes in Shareholders Equity 5 Consolidated Una |
|
| August 31, 2022 |
Check-Cap Reports Second Quarter 2022 Financial Results and Provides a Corporate Update Exhibit 99.1 Check-Cap Reports Second Quarter 2022 Financial Results and Provides a Corporate Update ISFIYA, Israel, August 31, 2022 - Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan?, the first and only patient-friendly, preparation-free screening test to detect polyps before they may t |
|
| August 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For August 2022 Commission File No. |
|
| August 11, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For August 2022 Commission File No. |
|
| August 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For August 2022 Commission File No. |
|
| June 23, 2022 |
Exhibit 99.1 Check-Cap Ltd. (NASDAQ: CHEK) Announces Receipt of Extension to Meet the Nasdaq's Minimum Bid Price Requirement ISFIYA, Israel, June 23, 2022 - Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan?, the first and only patient-friendly, preparation-free screening test to detect po |
|
| June 23, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For June 2022 Commission File No. |
|
| June 22, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For June 2022 Commission File No. |
|
| June 22, 2022 |
CHECK-CAP LTD. THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS Exhibit 99.2 CHECK-CAP LTD. THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS The undersigned hereby appoint(s) Alex Ovadia and Mira Rosenzweig, or either of them, attorneys or attorney of the undersigned, for and in the name(s) of the undersigned, with power of substitution and revocation in each to vote any and all ordinary shares, par value NIS 2.40 per share, of Check-Cap Ltd. (the ? |
|
| June 22, 2022 |
Exhibit 99.1 Check-Cap Ltd. Check-Cap Building 29 Abba Hushi Avenue P.O. Box 1271 Isfiya, 3009000 Israel NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS Dear Shareholder: We cordially invite you to attend an Extraordinary General Meeting of Shareholders of Check-Cap Ltd. (the ?Meeting?) to be held on Thursday, August 4, 2022, at 4:00 p.m. (Israel time) at our offices at the Check-Cap Build |
|
| June 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For June 2022 Commission File No. |
|
| June 1, 2022 |
Exhibit 99.1 Check-Cap Reports First Quarter 2022 Financial Results and Corporate Update Company initiated first part of its U.S. pivotal study in early May 2022 ISFIYA, Israel, June 1, 2022 - Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan?, the first and only patient-friendly, preparat |
|
| May 11, 2022 |
Check-Cap Announces Initiation of the U.S. Pivotal Trial Exhibit 99.1 Check-Cap Announces Initiation of the U.S. Pivotal Trial ISFIYA, Israel, May 11, 2022 - Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan?, the first and only patient-friendly, preparation-free screening test to detect polyps before they may transform into colorectal cancer (C |
|
| May 11, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For May 2022 Commission File No. |
|
| April 7, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For April 2022 Commission File No. |
|
| April 7, 2022 |
Exhibit 99.1 Check-Cap Reports Fourth Quarter and Full Year 2021 Financial Results Company anticipates initiation of the first part of its U.S. pivotal study in April 2022 ISFIYA, Israel, April 7, 2022 - Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan?, the first and only patient-friendl |
|
| April 6, 2022 |
Description of Securities Registered under Section 12 Exhibit 2.1 The descriptions of the securities contained herein summarize the material terms and provisions of the securities of Check-Cap Ltd. (the ?Company?), registered under Section 12 of the Securities Exchange Act of 1934. DESCRIPTION OF ORDINARY SHARES Ordinary Shares Our authorized and registered share capital is NIS 864,000,000 divided into 360,000,000 ordinary shares, nominal (par) value |
|
| April 6, 2022 |
Consent of Brightman Almagor Zohar & Co., independent registered public accounting firm eExhibit 15.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in Registration Statements on Form S-8 (No. 333-203384, 333-226490 and 333-259666) and in Registration Statements on Form F-3 (No. 333-211065, 333-225789 and 333-262401), of our report dated April 6 2022, relating to the financial statements of Check-Cap Ltd. (the ?Company?) and the |
|
| April 6, 2022 |
Certification of Chief Financial Officer Pursuant to Rule 13a-14(a)/15d-14(a) Exhibit 12.2 Certification Pursuant to Rule 13a-14(a) of the Exchange Act I, Mira Rosenzweig, certify that: 1. I have reviewed this annual report on Form 20-F of Check-Cap Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statemen |
|
| April 6, 2022 |
Certification of Chief Executive Officer Pursuant to Rule 13a-14(a)/15d-14(a) Exhibit 12.1 Certification Pursuant to Rule 13a-14(a) of the Exchange Act I, Alex Ovadia, certify that: 1. I have reviewed this annual report on Form 20-F of Check-Cap Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements w |
|
| April 6, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ? REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT O |
|
| April 6, 2022 |
Exhibit 13.1 Certification Pursuant to 18 U.S.C. Section 1350 Pursuant to U.S.C. Section 1350 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), each of the undersigned officers of Check- Cap Ltd. (the “Company”), does hereby certify, to such officer’s knowledge, that: The Annual Report on Form 20-F for the year ended December 3 |
|
| April 6, 2022 |
Exhibit 4.22 March 1, 2022 Holder of Warrants to Purchase Ordinary Shares issued in July 2021 Re: Amendment to Existing Warrants Dear Holder: Reference is hereby made to the offering on or about the date hereof (the ?Offering?) by Check-Cap Ltd. (the ?Company?) of (i) ordinary shares, par value NIS 2.40 per share (?Ordinary Shares?), (ii) Pre-Funded Warrants to purchase Ordinary Shares (?Pre-Funde |
|
| March 3, 2022 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this ?Agreement?) is dated as of March 1, 2022, between Check-Cap Ltd., a company organized under the laws of the State of Israel (the ?Company?), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a ?Purchaser? and collectively the ?Purchasers?). WHEREAS, subject to |
|
| March 3, 2022 |
Check-Cap Ltd. Announces $10 Million Registered Direct Offering Exhibit 99.1 Check-Cap Ltd. Announces $10 Million Registered Direct Offering ISFIYA, Israel, March 1, 2022 /PRNewswire/ - Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan?, the first and only patient-friendly, preparation-free screening test, to detect polyps before they may transform int |
|
| March 3, 2022 |
Filed Pursuant to Rule 424(b)(5) Registration No. 333-262401 PROSPECTUS SUPPLEMENT (To the Prospectus Dated February 7, 2022) CHECK-CAP LTD. 20,000,000 ordinary shares Warrants to Purchase up to 15,000,000 ordinary shares Placement Agent Warrants to Purchase up to 1,000,000 Ordinary Shares (and the Ordinary Shares underlying such Warrants and Placement Agent Warrants) We are offering 20,000,000 or |
|
| March 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For March 2022 Commission File No. |
|
| March 3, 2022 |
Exhibit 10.2 ORDINARY SHARE PURCHASE WARRANT CHECK-CAP LTD. Warrant Shares: Initial Exercise Date: March 3, 2022 Issue Date: March 3, 2022 THIS ORDINARY SHARE PURCHASE WARRANT (the ?Warrant?) certifies that, for value received, or its assigns (the ?Holder?) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the d |
|
| March 3, 2022 |
Form of Placement Agent Warrant. Exhibit 10.3 PLACEMENT AGENT ORDINARY SHARE PURCHASE WARRANT CHECK-CAP LTD. Warrant Shares: Initial Exercise Date: March 3, 2022 Issue Date: March 3, 2022 THIS PLACEMENT AGENT ORDINARY SHARE PURCHASE WARRANT (the ?Warrant?) certifies that, for value received, or its assigns (the ?Holder?) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set fort |
|
| March 1, 2022 |
Check-Cap Ltd. Announces $10 Million Registered Direct Offering Exhibit 99.1 Check-Cap Ltd. Announces $10 Million Registered Direct Offering ISFIYA, Israel, March 1, 2022 /PRNewswire/ - Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan?, the first and only patient-friendly, preparation-free screening test, to detect polyps before they may transform int |
|
| March 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For March 2022 Commission File No. |
|
| February 11, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* Check-Cap Ltd. (Name of Issuer) Ordinary shares, par value NIS 2.40 per share (Title of Class of Securities) M2361E203 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rul |
|
| February 7, 2022 |
Check-Cap Ltd. 29 Abba Hushi Avenue P.O. Box 1271 Isfiya, 3009000 Check-Cap Ltd. 29 Abba Hushi Avenue P.O. Box 1271 Isfiya, 3009000 Israel February 7, 2022 Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Check-Cap Ltd. Registration Statement on Form F-3 File No. 333-262401 VIA EDGAR Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Check-Cap Ltd. (the ?Registr |
|
| February 7, 2022 |
Check-Cap Announces FDA Approval of Amended IDE Application for Pivotal Study of C-Scan Exhibit 99.1 Check-Cap Announces FDA Approval of Amended IDE Application for Pivotal Study of C-Scan Company anticipates initiation of first part of pivotal study in the March-April 2022 timeframe ISFIYA, Israel, February 7, 2022 - Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan?, the fi |
|
| February 7, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For February 2022 Commission File No. |
|
| January 28, 2022 |
As filed with the Securities and Exchange Commission on January 28, 2022 F-3 1 zk2227124.htm F-3 As filed with the Securities and Exchange Commission on January 28, 2022 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CHECK-CAP LTD. (Exact name of registrant as specified in its charter) Israel 3844 Not Applicable (State or other jurisdiction of incorporation o |
|
| January 5, 2022 |
Check-Cap Issues Letter to Shareholders Exhibit 99.1 Check-Cap Issues Letter to Shareholders ISFIYA, Israel, Jan. 5, 2022 /PRNewswire/ - Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan?, the first and only patient-friendly preparation-free screening test to detect polyps before they may transform into colorectal cancer (CRC), |
|
| January 5, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For January 2022 Commission File No. |
|
| December 23, 2021 |
Check-Cap Announces Receipt of Nasdaq Minimum Bid Price Notification Exhibit 99.1 Check-Cap Announces Receipt of Nasdaq Minimum Bid Price Notification ISFIYA, Israel, December 23, 2021, Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan?, the first and only patient-friendly, preparation-free screening test to detect polyps before they may transform into colo |
|
| December 23, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For December 2021 Commission File No. |
|
| December 9, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For December 2021 Commission File No. |
|
| November 22, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For November 2021 Commission File No. |
|
| November 22, 2021 |
Exhibit 99.1 Check-Cap Announces Publication of Peer-Reviewed Article Highlighting Safety and Patient Satisfaction Data for its Colorectal Screening Test, C-Scan? Patients who underwent the procedure, as part of the 2019 U.S. pilot study, were significantly more likely to recommend C-Scan test compared to colonoscopy ISFIYA, Israel, November 22, 2021 - Check-Cap Ltd. (the "Company" or "Check-Cap") |
|
| November 3, 2021 |
Check-Cap Reports Third Quarter 2021 Financial Results and Corporate Update Exhibit 99.1 Check-Cap Reports Third Quarter 2021 Financial Results and Corporate Update ISFIYA, Israel, November 3, 2021 - Check-Cap Ltd. (the ?Company? or ?Check-Cap?) (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan?, the first and only patient-friendly, preparation-free screening test to detect polyps before they may transform in |
|
| November 3, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For November 2021 Commission File No. |
|
| November 2, 2021 |
Exhibit 99.1 Check-Cap Announces Grant of Patent Covering C-Scan's Proprietary Tracking Technology in the U.S. and Additional Major Market Territories Patent valid through May 2034 ISFIYA, Israel, November 2, 2021 - Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan?, the first and only pat |
|
| November 2, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For November 2021 Commission File No. |
|
| October 29, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K/A (Amendment No. |
|
| October 29, 2021 |
Notice and Proxy Statement for the 2021 Annual General Meeting of Shareholders EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 Exhibit 99.1 Check-Cap Ltd. Check-Cap Building 29 Abba Hushi Avenue P.O. Box 1271 Isfiya, 3009000 Israel NOTICE OF 2021 ANNUAL GENERAL MEETING OF SHAREHOLDERS Dear Shareholder: We cordially invite you to attend the 2021 Annual General Meeting of Shareholders of Check-Cap Ltd. (the “Meeting”) to be held on Thursday, December 2, 2021, at 4:00 p.m. (Israel time) |
|
| October 29, 2021 |
CHECK-CAP LTD. THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS Exhibit 99.2 CHECK-CAP LTD. THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS The undersigned hereby appoint(s) Alex Ovadia and Mira Rosenzweig, or either of them, attorneys or attorney of the undersigned, for and in the name(s) of the undersigned, with power of substitution and revocation in each to vote any and all ordinary shares, par value NIS 2.40 per share, of Check-Cap Ltd. (the ? |
|
| October 21, 2021 |
Exhibit 99.1 Check-Cap Ltd. Check-Cap Building 29 Abba Hushi Avenue P.O. Box 1271 Isfiya, 3009000 Israel NOTICE OF 2021 ANNUAL GENERAL MEETING OF SHAREHOLDERS Dear Shareholder: We cordially invite you to attend the 2021 Annual General Meeting of Shareholders of Check-Cap Ltd. (the ?Meeting?) to be held on Thursday, December 2, 2021, at 4:00 p.m. (Israel time) at our offices at the Check-Cap Buildi |
|
| October 21, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For October 2021 Commission File No. |
|
| October 21, 2021 |
CHECK-CAP LTD. THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS Exhibit 99.2 CHECK-CAP LTD. THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS The undersigned hereby appoint(s) Alex Ovadia and Mira Rosenzweig, or either of them, attorneys or attorney of the undersigned, for and in the name(s) of the undersigned, with power of substitution and revocation in each to vote any and all ordinary shares, par value NIS 2.40 per share, of Check-Cap Ltd. (the ? |
|
| October 18, 2021 |
Exhibit 99.1 Check-Cap Announces Expansion of Manufacturing Capacity and Production Line to Support U.S. Pivotal Study Initiation ISFIYA, Israel, October 18, 2021 - Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan?, the first and only patient-friendly, preparation-free screening test to d |
|
| October 18, 2021 |
6-K 1 zk2126659.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For October 2021 Commission File No. 001-36848 Check-Cap Ltd. Check-Cap Building Abba Hushi Avenue P.O. Box 1271 Isfiya, 30090 Mount Carmel, Israel (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES. |
|
| September 20, 2021 |
As filed with the Securities and Exchange Commission on September 20, 2021 As filed with the Securities and Exchange Commission on September 20, 2021 Registration No. |
|
| September 1, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For September 2021 Commission File No. |
|
| September 1, 2021 |
Check-Cap Appoints Dr. Hanit Brenner-Lavie as Vice President of Clinical Affairs Exhibit 99.1 Check-Cap Appoints Dr. Hanit Brenner-Lavie as Vice President of Clinical Affairs ISFIYA, Israel, September 1, 2021 - Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan?, the first and only patient-friendly, preparation-free screening test to detect polyps before they may transf |
|
| August 5, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For August 2021 Commission File No. |
|
| August 5, 2021 |
Check-Cap Reports Second Quarter 2021 Financial Results and Corporate Update Exhibit 99.1 Check-Cap Reports Second Quarter 2021 Financial Results and Corporate Update ISFIYA, Israel, August 5, 2021 - Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan?, the first and only patient-friendly, preparation-free screening test to detect polyps before they may transform int |
|
| August 5, 2021 |
Exhibit 99.2 CHECK CAP LTD. CONSOLIDATED UNAUDITED FINANCIAL STATEMENTS AS OF JUNE 30, 2021 CHECK CAP LTD. CONSOLIDATED UNAUDITED FINANCIAL STATEMENTS AS OF JUNE 30, 2021 Table of Contents Page Financial Statements: Consolidated Unaudited Balance Sheets 3 Consolidated Unaudited Statements of Comprehensive Loss 4 Consolidated Unaudited Statements of Changes in shareholders Equity 5 Consolidated Una |
|
| July 2, 2021 |
Form of Placement Agent Warrant. Exhibit 10.3 PLACEMENT AGENT ORDINARY SHARE PURCHASE WARRANT CHECK-CAP LTD. Warrant Shares: Initial Exercise Date: , 2021 Issue Date: , 2021 THIS PLACEMENT AGENT ORDINARY SHARE PURCHASE WARRANT (the ?Warrant?) certifies that, for value received, or its assigns (the ?Holder?) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time |
|
| July 2, 2021 |
Exhibit 10.2 EXHIBIT A ORDINARY SHARE PURCHASE WARRANT CHECK-CAP LTD. Warrant Shares: Initial Exercise Date: , 2021 Issue Date: , 2021 THIS ORDINARY SHARE PURCHASE WARRANT (the ?Warrant?) certifies that, for value received, or its assigns (the ?Holder?) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date |
|
| July 2, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For July 2021 Commission File No. |
|
| July 2, 2021 |
Filed Pursuant to Rule 424(b)(5) Registration No. 333-225789 PROSPECTUS SUPPLEMENT (To the Prospectus Dated July 16, 2018) CHECK-CAP LTD. 25,925,926 Ordinary Shares Warrants to Purchase up to 25,925,926 Ordinary Shares Placement Agent Warrants to Purchase up to 1,296,296 Ordinary Shares (and the Ordinary Shares underlying such Warrants and Placement Agent Warrants) We are offering 25,925,926 ordin |
|
| July 2, 2021 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this ?Agreement?) is dated as of June 30, 2021, between Check-Cap Ltd., a company organized under the laws of the State of Israel (the ?Company?), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a ?Purchaser? and collectively the ?Purchasers?). WHEREAS, subject to |
|
| July 2, 2021 |
Check-Cap Ltd. Announces $35 Million Registered Direct Offering Exhibit 99.1 Check-Cap Ltd. Announces $35 Million Registered Direct Offering ISFIYA, Israel, June 30, 2021 - Check-Cap Ltd. (the ?Company? or ?Check-Cap?) (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan?, the first and only patient-friendly, preparation-free screening test, to detect polyps before they may transform into colorectal |
|
| June 17, 2021 |
CHEK / Check-Cap Ltd. / GREEN FROG INVESTMENTS INC - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION STATEMENT TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1 (b) (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2 (b) (Amendment No. )* Check-Cap Ltd. (Name of Issuer) Ordinary Shares, par value NIS 2.40 per share (Title of Class of Securities) M2361E203 (CUSIP Number) June 14, 2 |
|
| May 12, 2021 |
Check-Cap Reports First Quarter 2021 Financial Results and Corporate Update Exhibit 99.1 Check-Cap Reports First Quarter 2021 Financial Results and Corporate Update ISFIYA, Israel, May 12, 2021 - Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan?, the first and only patient-friendly, preparation-free screening test, to detect polyps before they may transform into |
|
| May 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For May 2021 Commission File No. |
|
| March 25, 2021 |
As filed with the Securities and Exchange Commission on March 25, 2021 Registration No. |
|
| March 19, 2021 |
Exhibit 99.1 Check-Cap Reports Fourth Quarter and Full Year 2020 Financial Results Received FDA IDE Approval for Pivotal Study of C-Scan® Company on track to initiate a U.S. pivotal study of C-Scan in late 2021 ISFIYA, Israel, March 19, 2021 - Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-S |
|
| March 19, 2021 |
Current Report of Foreign Issuer - 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For March 2021 Commission File No. |
|
| March 18, 2021 |
Amended and Restated Articles of Association of the Registrant Exhibit 1.1 THE COMPANIES LAW, 5759-1999 A LIMITED LIABILITY COMPANY ARTICLES OF ASSOCIATION OF CHECK-CAP LTD. Preliminary 1. Definitions; Interpretation (a) In these Articles, the following terms (whether or not capitalized) shall bear the meanings set forth opposite them, respectively, unless the subject or context requires otherwise: ?Articles? shall mean these Articles of Association, as amend |
|
| March 18, 2021 |
Certification of Chief Executive Officer Pursuant to Rule 13a-14(a)/15d-14(a) Exhibit 12.1 Certification Pursuant to Rule 13a-14(a) of the Exchange Act I, Alex Ovadia, certify that: 1. I have reviewed this annual report on Form 20-F of Check-Cap Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements w |
|
| March 18, 2021 |
Certification of Chief Financial Officer Pursuant to Rule 13a-14(a)/15d-14(a) Exhibit 12.2 Certification Pursuant to Rule 13a-14(a) of the Exchange Act I, Mira Rosenzweig, certify that: 1. I have reviewed this annual report on Form 20-F of Check-Cap Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statemen |
|
| March 18, 2021 |
Exhibit 13.1 Certification Pursuant to 18 U.S.C. Section 1350 Pursuant to U.S.C. Section 1350 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), each of the undersigned officers of Check- Cap Ltd. (the ?Company?), does hereby certify, to such officer?s knowledge, that: The Annual Report on Form 20-F for the year ended December 3 |
|
| March 18, 2021 |
Exhibit 2.1 The descriptions of the securities contained herein summarize the material terms and provisions of the securities of Check-Cap Ltd. (the ?Company?), registered under Section 12 of the Securities Exchange Act of 1934. DESCRIPTION OF ORDINARY SHARES Ordinary Shares Our authorized and registered share capital is NIS 216,000,000 divided into 90,000,000 ordinary shares, nominal (par) value |
|
| March 18, 2021 |
Consent of Brightman Almagor Zohar & Co., independent registered public accounting firm Exhibit 15.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in Registration Statements on Form S-8 (No. 333-203384 and 333-226490) and in Registration Statements on Form F-3 (No. 333-211065 and No. 333- 225789), of our report dated March 18, 2021, relating to the financial statements of Check-Cap Ltd. (the ?Company?) appearing in this Annual R |
|
| March 18, 2021 |
Exhibit 4.28 EXCLUSIVE LICENSE AGREEMENT THIS EXCLUSIVE LICENSE AGREEMENT (?AGREEMENT?) is made and entered into this 26th day of February, 2021 (?EFFECTIVE DATE?), by and between THE CURATORS OF THE UNIVERSITY OF MISSOURI, a public corporation of the State of Missouri having an office at The Technology Advancement Office, Mizzou North, Room 706, 115 Business Loop 70W, Columbia, Missouri 65211-837 |
|
| March 18, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ? REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT O |
|
| March 15, 2021 |
Current Report of Foreign Issuer - 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For March 2021 Commission File No. |
|
| March 15, 2021 |
Exhibit 99.1 Check-Cap Receives FDA IDE Approval for Pivotal Study of C-Scan® Company expects to commence U.S. pivotal trial in late 2021 ISFIYA, Israel, March 15, 2021 - Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and only patient-friendly, preparation-free, screening te |
|
| February 9, 2021 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* Check-Cap Ltd. (Name of Issuer) Ordinary Shares, par value NIS 2.40 per share (Title of Class of Securities) M2361E203 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant t |
|
| January 29, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Check-Cap Ltd. (Name of Issuer) Ordinary shares, par value NIS 2.40 per share (Title of Class of Securities) M2361E203 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rul |
|
| January 27, 2021 |
Check-Cap Issues Letter to Shareholders Exhibit 99.1 Check-Cap Issues Letter to Shareholders ISFIYA, Israel, January 27, 2021 - Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and only patient-friendly preparation-free screening test to detect polyps before they may transform into colorectal cancer, today issued th |
